Tonix Pharmaceuticals broke ground in August of 2021 on the 45,000-sf Advanced Development Center in Dartmouth, Mass. Enabling the production of clinical-stage vaccines for COVID-19 and other infectious diseases, the BSL-2 facility will utilize single-use bioreactors and purification suites for optimal efficiency and flexibility. The cGMP center will also offer state-of-the-art research, development, and analytical suites. Approximately 70 scientists, technicians, and manufacturing staff will work in the turnkey building.
The fast-tracked development includes renovation of an existing 40,000-sf structure in the New Bedford Business Park and construction of a 4,000-sf addition. Design-build contractor The Cardinal Group and engineering firm IPS are leveraging an integrated project delivery approach to accelerate the construction timeline so that operations can commence in spring of 2022.